The traditional management of onychomycosis includes mechanical, chemi
cal, and surgical approaches, as well as topical and oral antifungal m
edications. Topical preparations have been consistently disappointing,
and the tendency in later years has been to rely on two systemic agen
ts-griseofulvin and ketoconazole-for management of more severe or reca
lcitrant infections. However, both drugs require a long duration of th
erapy (4 to 6 months for fingernails, 10 to 18 months for toenails). E
ven with such prolonged treatment, the overall success rate is only ab
out 15% to 30% for toenail infections and 50% to 70% for fingernail in
fections. Furthermore, both griseofulvin and ketoconazole have numerou
s potential side effects and drug/drug interactions. Therefore, labora
tory monitoring should be performed during the course of treatment wit
h these agents and they should be used only after evaluation of the pa
tient's current medical status and a review of concomitant medications
.